Compare Bristol-Myers Squibb Co (BMY) vs VNET Group Inc (VNET) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bristol-Myers Squibb Co vs VNET Group Inc — how do they compare? Bristol-Myers Squibb Co trades at $63.41 (market cap $129.94B), while VNET Group Inc trades at $7.51 (market cap $2.14B). The key difference: Bristol-Myers Squibb Co is far larger — about 60.7× VNET Group Inc's market cap, and Bristol-Myers Squibb Co pays a 3.96% dividend while VNET Group Inc pays none. Which is the better fit depends on your goals.
| BMY | VNET | |
|---|---|---|
Market Cap | $129.94B | $2.14B |
Sector | Health | Technology |
52-Week High | $65.89 | $14.03 |
52-Week Low | $42.60 | $6.29 |
Enterprise Value | $163.92B | $5.29B |
Dividend Yield | 3.96% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Bristol-Myers Squibb Co
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Read more on BMY →About VNET Group Inc
VNET Group, formerly 21Vianet, is a leading carrier-neutral data center services provider in China. It operates a dual-core strategy: a large-scale retail business serving over 7,000 enterprise customers and an aggressive wholesale segment (Hyperscale 2.0) designed to meet the high-density power and cooling demands of large-scale AI and cloud platforms.
Read more on VNET →
